Research photo from the National Cancer Institute, shared via Unsplash. (NCI Photo) When Luca Foschini, head of Seattle's ...

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.

Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...

Biotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In ...

After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bisepcifics ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana ...

Elicio Therapeutics shares plunged after the biotech firm priced a secondary offering at a significant discount to its Wednesday closing price. Shares fell 18% to $7.86 premarket.

Shares in clinical-stage biotechnology company Cargo Therapeutics (CRGX) have plunged after it scrapped trials of a cancer ...

Investing.com -- Immunome, Inc. (NASDAQ: IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company, known ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.